Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Activation of NK and CD8+ T-Cells with a Novel IL-15 and TGF-Beta Receptor Fusion Protein Confers Anti-Tumor Immunity

Spencer Ng, B.Sc., Jiusheng Deng, PhD, Raghavan Chinndurai, PhD, Shala Yuan, MS, Andrea Pennati, PhD, Jacques Galipeau, MD

Blood (2015) 126 (23): 3421.

https://doi.org/10.1182/blood.V126.23.3421.3421

Published: 2015

Journal Articles

A GM-CSF and IL-4 Fusion Cytokine Triggers Conversion of B-Cells to Tumoricidal Effectors

Jiusheng Deng, PhD, Pingxin Li, PhD, Andrea Pennati, PhD, Shala Yuan, MSc, Hsiang-Chuan (Jeremy) Hsieh, BSc, Jian Hui Wu, PhD, Jacques Galipeau, MD

Blood (2012) 120 (21): 1048.

https://doi.org/10.1182/blood.V120.21.1048.1048

Published: 2012

Journal Articles

GM-CSF and IL-4 Derived Fusion Cytokine Reprograms Leukemic B-Cells to Anti-CLL Effectors

Jiusheng Deng, PhD, Andrea Pennati, PhD, Pingxin Li, PhD, Shala Yuan, MSc, Jordan Murphy, BS, Spencer Ng, BSc, Rajni Sinha, MD, MRCP, Christopher R. Flowers, MD, Jacques Galipeau, MD

Blood (2012) 120 (21): 4606.

https://doi.org/10.1182/blood.V120.21.4606.4606

Published: 2012

Journal Articles

A Novel Dendritic Cell Population Generated by Fusing Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-21 Induces Tumor-Antigen Specific Immunity

Patrick Williams, Manaf Bouchentouf, Moutih Rafei, Dr., Raphaelle Romieu-Mourez, Ph.D., Hsiang-Chuan (Jeremy) Hsieh, BSc, Marie-Noelle Boivin, Shala Yuan, Kathy-Ann Forner, Elena Birman, Jacques Galipeau, MD, FRCPC

Blood (2010) 116 (21): 5177.

https://doi.org/10.1182/blood.V116.21.5177.5177

Published: 2010

Journal Articles

Mesenchymal stromal cell–derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction

Moutih Rafei, Jeremy Hsieh, Simon Fortier, MengYang Li, Shala Yuan, Elena Birman, Kathy Forner, Marie-Noelle Boivin, Karen Doody, Michel Tremblay, Borhane Annabi, Jacques Galipeau

Blood (2008) 112 (13): 4991–4998.

https://doi.org/10.1182/blood-2008-07-166892

Published: 2008

NARROW

Activation of NK and CD8+ T-Cells with a Novel IL-15 and TGF-Beta Receptor Fusion Protein Confers Anti-Tumor Immunity

A GM-CSF and IL-4 Fusion Cytokine Triggers Conversion of B-Cells to Tumoricidal Effectors

GM-CSF and IL-4 Derived Fusion Cytokine Reprograms Leukemic B-Cells to Anti-CLL Effectors

A Novel Dendritic Cell Population Generated by Fusing Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-21 Induces Tumor-Antigen Specific Immunity

Mesenchymal stromal cell–derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction

Email alerts

ASH Publications

American Society of Hematology

Activation of NK and CD8+ T-Cells with a Novel IL-15 and TGF-Beta Receptor Fusion Protein Confers Anti-Tumor Immunity

A GM-CSF and IL-4 Fusion Cytokine Triggers Conversion of B-Cells to Tumoricidal Effectors

GM-CSF and IL-4 Derived Fusion Cytokine Reprograms Leukemic B-Cells to Anti-CLL Effectors

A Novel Dendritic Cell Population Generated by Fusing Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-21 Induces Tumor-Antigen Specific Immunity

Mesenchymal stromal cell–derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only